8-K

Company

Cellectar Biosciences, Inc.

Filed

May 4, 2023

Period of Report

May 4, 2023

Accession Number

0001104659-23-055815

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →